Pascal E. R. Girin - 01 Jul 2024 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jul 2024, 17:21:53 UTC
Prior SEC filing
17 May 2024
Next SEC filing
02 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard F. Mattern, by Power of Attorney for Pascal E. R. Girin

Key filing fact

Pascal E. R. Girin filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 02 Jul 2024.

Key facts

  • This page summarizes Pascal E. R. Girin's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jul 2024, 17:21.

Change

  • Previous filing in this sequence was filed on 17 May 2024.
  • Current net transaction value: +$7,185.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Award

Transaction value
$7,185
Shares
+1,333
Change %
+1.8%
Price
$5.39
Shares after
73,530
Date
01 Jul 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 28, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .